St Luke Home Health And Hospice Medicare Approved Location: 271 F.e. Sellers Highway / Po Box 803, Monticello, Mississippi 39654 Phone: (601) 587-1142 |
News Archive
A new poll by the Harvard School of Public Health and The Boston Globe finds 59% of Massachusetts residents who are aware of the state's health reform legislation, which was enacted in 2006, support it. A little more than one in four oppose it (28%), and 13% are not sure. The level of public support for the law has declined somewhat in the last year, from 69% saying they support the law in 2008 to 59% in the current poll.
"Missouri law now contains a direct challenge to the federal health care law passed earlier this year. Primary voters approved Proposition C by a wide margin Tuesday. ... The measure is intended to invalidate in Missouri a key element of the federal health care law passed by Congress and signed by President Barack Obama in March. That law requires individuals to purchase health insurance beginning in 2014."
Tengion, Inc. a leader in regenerative medicine, presented new data on Saturday, October 23, 2010 in a podium presentation at the American Society for Transplantation's Annual Scientific Exchange in Orlando, FL. The presentation highlighted new early data from Tengion's Neo-Kidney Augment development program demonstrating promising improvements in kidney function with an autologous cellular therapy approach to kidney regeneration in a canine model of chronic kidney disease.
Scientists have uncovered how nerve cells in the spinal cord are organized in precise patterns during embryo development - a finding that could give insight into regenerative medicine.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-PCS, an RNAi therapeutic for the treatment of severe hypercholesterolemia.
› Verified 5 days ago